Research Interests
Author Statistics
#Papers: 293
#Citation: 11013
H-Index: 54
G-Index: 98
Sociability: 9
Diversity: 2
Activity: 20
- 合作者
- 学生
- 导师

Mohammed Kashani-Sabet合作论文数
18

Stanley P. L. Leong合作论文数
California Pacific Medical Center and Research Institute, San Francisco14

Mehdi Nosrati合作论文数
Helen Diller Family Comprehensive Cancer Center, University of California San Francisco11

David R Minor合作论文数
9

Jeffrey A Sosman合作论文数
Division of Hematology and Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University8

James R Miller合作论文数
7

Rene Gonzalez合作论文数
University of Colorado Denver7

Omid Hamid合作论文数
The Angeles Clinic and Research Institute;Cedars Sinai7

Jeffrey S. Weber合作论文数
Langone Hospitals, New York University;Department of Medicine, Grossman School of Medicine, New York University7

Keith Flaherty合作论文数
Cancer Center, Mass General Research Institute, Massachusetts General Hospital;Henri and Belinda Termeer Center for Targeted Therapy, Cancer Center, Massachusetts General Hospital;Harvard Medical School6

Patrick Hwu合作论文数
Moffitt Cancer Center;Immatics6

Elham Vosoughi合作论文数
5

Georgina Long合作论文数
Faculty of Medicine and Health, The University of Sydney;Melanoma Institute Australia5

Lynn M. Schuchter合作论文数
Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania5

Alain Algazi合作论文数
Divisions of Hematology & Oncology, Department of Medicine, School of Medicine, University of California, San Francisco;Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco5

Richard F. Kefford合作论文数
5

Jeffrey R. Infante合作论文数
From the Department of Pediatrics and the Department of Health Policy and Epidemiology, University of Florida College of Medicine5

Igor Puzanov合作论文数
Roswell Park Comprehensive Cancer Center5

Wen-Jen Hwu合作论文数
4

John Moretto合作论文数
4

Dae Won Kim合作论文数
4

Karl Lewis合作论文数
Meinig School of Biomedical Engineering, College of Engineering, Cornell University4

Kudchadkar Ragini R合作论文数
4

Adil Daud合作论文数
Department of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center4

Michael A. Davies合作论文数
Department of Melanoma Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center4

Dar Altaf A合作论文数
4

Jeffrey Ross合作论文数
Foundation Medicine, Inc;Department of Pathology and Laboratory Medicine, Albany Medical College;Albany Medical Center Hospital4

Peng Sun合作论文数
Graduate School, Chinese Academy of Sciences4

Liliana Soroceanu合作论文数
4

Pierre-Yves Desprez合作论文数
California Pacific Medical Center, Research Institute4

Sean D. Mcallister合作论文数
4

Jonathan S. Cebon合作论文数
4

Brian M. Parrett合作论文数
3

Kiran Patel合作论文数
3

Agop Y. Bedikian合作论文数
Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center3

Sherri Millis合作论文数
3

Sapna Patel合作论文数
University of Colorado Cancer Center3

Jason J Luke合作论文数
Division of Oncology, Department of Medicine, School of Medicine, University of Pittsburgh;Immunotherapy and Drug Development Center, UPMC Hillman Cancer Center3

Jennifer J Wheler合作论文数
The University of Texas MD Anderson Cancer Center3

Vladimir Bezrookove合作论文数
Res Inst, Calif Pacific Med Ctr3

Rodabe N. Amaria合作论文数
Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center3

Marlana Orloff合作论文数
3

James Cleaver合作论文数
Department of Dermatology, University of California, San Francisco3

Antoni Ribas合作论文数
Jonsson Comprehensive Cancer Center;Department of Surgery, University of California Los Angeles;Parker Institute for Cancer Immunotherapy Center, University of California Los Angeles3

David De Semir合作论文数
3

Brendan D. Curti合作论文数
Providence Health & Services;Earle A. Chiles Research Institute, Providence Cancer Institute3

Aung Naing合作论文数
Investigational Cancer Therapeutics (Phase I Program), University of Texas M. D. Anderson Cancer Center3

Razelle Kurzrock合作论文数
Moores Cancer Center, University of California San Diego;Division of Hematology Oncology, School of Medicine, University of California San Diego3

David S Hong合作论文数
Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center3
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn